New dual heart pump offers hope for patients with End-Stage heart failure
NCT ID NCT07233876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called DuoCor 2, which is a mechanical pump that helps both sides of the heart pump blood. It is for people with advanced heart failure in both ventricles who have few other options. The study will enroll 50 adults and measure how many survive for 6 months, either with the device, after a transplant, or after heart recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medizinische Hochschule Hannover
Hanover, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Dual-Chamber heart pump save the failing heart?
- Can a mechanical heart pump offer a lifeline for advanced heart failure?
- Heart-Kidney link under microscope in advanced heart failure study
- New heart pump offers hope for advanced heart failure patients
- Could LVAD patients ditch aspirin? new trial aims to find out
- Stem cell injection during bypass surgery aims to repair damaged hearts